Eloxx Pharmaceuticals【ELOX】銘柄情報

Eloxx Pharmaceuticals Inc (ELOX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

3.82

( - )

買値

3.60

売値

3.75

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

前日終値

3.82

始値

時刻

最終取引時間

平均取引量 (3 か月)

財務取引量

VWAP

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates

First two subjects dosed in Phase 1 clinical trial of ZKN-013; ZKN-013 is being developed for the potential...

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates

ELX-02 Granted Orphan Drug Designation (ODD) from U.S. Food and Drug Administration (FDA) for Treatment of...

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare...

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ELOX - Frequently Asked Questions (FAQ)

What is the current Eloxx Pharmaceuticals Inc share price?

The current share price of Eloxx Pharmaceuticals Inc is US$ 3.82

What is the 1 year trading range for Eloxx Pharmaceuticals Inc share price?

Eloxx Pharmaceuticals Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year

AJH92 5分前

Share Structure - Updated June 6, 2026

Company Verified profile

Transfer Agent Verified

No change - no dilution to Outstanding Shares after the 68M reduction on February 14, 2026

Authorized Shares: 800,000,000

Outstanding Sha

EVLI

TKS PARTY 7分前

M1, Nothing less than the JV Partnership and the build -out, it's been said this is an all or nothing deal. IT sure feels like it. With a big pile pf dirt on the side. The new business out of the country is probably a Tom Ireland deal. I would not think a dollar amount will be attached to it, thus a

CBRF

Boat Shoes Warrior 9分前

My Man! Warrior! Like ole times!

FNMA

Major Profits 9分前

"...I say DIVIDEND gets done 2-3 weeks or less.."
You said this on 3/25/26, over TWO MONTHS ago:
Sounds like the Dividend is going to be A O.K. Finra just wanted some information from OTCM markets. Their counsel is working on it tomorrow.
But, who knows, maybe you'll be correct.

BCDS

Boat Shoes Warrior 10分前

Pennies on a dollar

FNMA

sharpie510 12分前

Pioneering Australian doctor Richard Scolyer has died, three years after being diagnosed with an aggressive brain tumour.

https://www.bbc.com/news/articles/c14yz5jg476o

NWBO

Krombacher 13分前

Stock_Barber.

A surgeon's track record is measured by surgeries performed — not by patients who refused the operation.

The only company that has actually performed this surgery is Overstock.

They succeeded.

That's a 100% success rate among

DBMM

Large Green 14分前

Ron, yes, makes a lot of sense. Now I do not believe everything only filings, PR, actions that can be verified or things that make sense when looked at case as a whole after connecting the dots available. Examples are like these that follow.

1) Form D, two of them and Paladin Acquisit

RKT

3331 14分前

BIEL + ELECTROME IS HUGE!
https://i.postimg.cc/5tdq6KKt/BCO-44b06f2f-71ed-407e-8099-d30b0f6b9a13.png

3331 14分前

BIEL CEO just posted:
https://youtu.be/egrh742nJnU?si=J81TYGLJGxU8fY71

PEACHMAN 15分前

002 is where this POS stock is headed

LBRG

jimr1717 17分前

Absolutely Peach, you are right on this

“unlike their American counterparts”

So the US Cattle farmers are Not Fooled and the India Cattle farmers are Not Fooled.

SURAEC isn't fooled either,

Using bagasse in beef cattle diets as a hay subst

IFUS

chainma1l 18分前

Big truck, bro!

SNTX

LOB 20分前

https://www.google.com/search?q=BITCOIN+price&ei=rHgGZPfPCPSlkPIPvMOwoAw&ved=0ahUKEwj31cL2u8j9AhX0EkQIHbwhDMQQ4dUDCBA&uact=5&oq=BITCOIN+price&gs_lcp=Cgxnd3Mtd2l6LXNlcnAQAzILCAAQgAQQsQMQgwEyCwgAELEDEIMBEJECMgsIABCxAxCDARCRAjIICAAQsQMQkQIyCAgAEIAEELEDMggIABCABBCxAzIICAAQgAQQsQMyCAgAEIAEELEDMggIABCABBC

BCDS

FormalMHRAconsultant 20分前

Thank you for clarifying for your investor peers what we've pretty much been telling everyone all along: the CHM just provides advice, it does not make decisions, and that there was no indication that what they wrote in the minutes was directed at DCVax-L specifically, if at allI think in the bolded

NWBO

PEACHMAN 20分前

no one is loading this POS

1 week
-0.017
-6.44%
0.264
0.279
0.2452
2,036,361
0.257446
1 month
-0.1116
-31.12%
0.3586
0.3586
0.2452
1,446,562
0.275737
3 months

COSM

Stock_Barber 20分前

I put my credibility on the table publicly.
Indeed... AND THE TABLE IS EMPTY!

Your 100% FAILED track record speaks for itself and is EASILY verified... save your breath... NO ONE IS LISTENING!

https://external-content.duckduckgo.com/iu/?u=https%3A

DBMM

Just give me $1.50 21分前

Correct, but the $2.11+ buyer will finish the job.

Which also goes back to my point that we are a specialty pharma.

Thanks.

ELTP

JJ8 21分前

John Murphy, author of many books on technical analysis ranking it a score based on six key indicators covering different timeframes. These indicator scores are then sorted and assigned a technical rank ranging from 0.0 to 99.9.
QSI: 33.3, (-40.2); SCTR Universe: Small Cap

QSI

jour_trader 22分前

We all know it’s not going anywhere and needs further studies. Company has stated they aren’t pursuing them. Been in purgatory pending status for how many years now with FDA?

ELTP

AJH92 22分前

Share Structure - Updated June 6, 2026

Verified Company Profile

Transfer Agent Verified

No change - no dilution since October 2, 2025 - over 8 months

Authorized Shares:22,000,000,000

Outstanding Shares: 21,460,268,251

PSRU

barnstormer 23分前

Gary, I consider it AIs analysis. All I did was supply the material and do some clarifying and challenging to try and make sure it wasn't a version meant to please me.

On your other question, GMP doesn't transfer so the EDEN unit would have qualified be at each site. That would stand

NWBO

DarthYoda 24分前

"Charlotte’s Web CEO Sees Healthcare Integration And Industry Alignment Driving The Next Phase Of Cannabinoid Growth":
June 5, 2026
For Morachnick, the future depends on moving beyond industry divisions and toward a more collaborative approach. He will bring that perspective to the Chi

CWBHF

Krombacher 24分前

Jetmek.

Your best post yet. Genuinely. Formatted, numbered, color-coded. I'll give it the response it deserves.

But first — you still haven't answered the question.

I put my credibility on the table publicly. If the Series 2 preferred dividend settles cle

DBMM

LOB 27分前

NSAV = Fake. BCDS = REAL and I say DIVIDEND gets done 2-3 weeks or less..

BCDS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Eloxx Pharmaceuticals Inc (ELOX)

Eloxx Pharmaceuticals Inc (ELOX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

ELOX 最新ニュース

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

ELOX - Frequently Asked Questions (FAQ)

ELOX 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Eloxx Pharmaceuticals Inc (ELOX)

Eloxx Pharmaceuticals Inc (ELOX) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

ELOX 最新ニュース

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates

Eloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form 8-K - Current report

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Form 8-K - Current report

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

ELOX - Frequently Asked Questions (FAQ)

ELOX 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS